title: Comment on Hempe et al. The hemoglobin glycation index identifies subpopulations with harms or benefits from intensive treatment in the ACCORD trial. Diabetes Care 2015;38:1067-1074.
authors.affiliation: Oregon Health & Science University, Portland, OR riddlem@ohsu.edu.
authors.forename: Matthew C
authors.initials: MC
authors.lastname: Riddle
authors.affiliation: Population Health Research Institute and McMaster University, Hamilton, Canada.
authors.forename: Hertzel C
authors.initials: HC
authors.lastname: Gerstein
mesh_terms: D003924:Diabetes Mellitus, Type 2 / Q000517:prevention & control*; D003925:Diabetic Angiopathies / Q000517:prevention & control*; D005260:Female; D006801:Humans; D007004:Hypoglycemic Agents / Q000009:adverse effects*; D008297:Male
chemical_list: D007004:Hypoglycemic Agents